RESUMO
Prognostication of patients with cirrhosis is complex, depending on more than just the severity of liver disease. Scores such as the model for end-stage liver disease (MELD) and Child Pugh can assist with prognostication, yet by focusing on physiological parameters they fail to completely capture the elements contributing to a patient's clinical status. Evidence is increasing to support an important role for physical functioning in patient outcomes. Frailty has been increasingly recognised in medical literature over recent years, including in hepatology where it is identified in nearly half of cirrhosis patients. It is a complex construct consisting of multisystemic physiological decline and increased vulnerability to stressors. Diagnosis is complicated by lack of a consensus definition and measurement tool for frailty in cirrhosis. Frailty heralds a poor prognosis, predicting increased morbidity and mortality both pre- and postliver transplant, independent of MELD score. It is thought to be reversible, with promising data supporting prehabilitation and lifestyle intervention programs. In the future, assessment of patients with cirrhosis is likely to incorporate a measure of frailty, however, further research is required.
Assuntos
Doença Hepática Terminal/diagnóstico , Fragilidade/etiologia , Cirrose Hepática/complicações , Sarcopenia/etiologia , Atividades Cotidianas , Doença Hepática Terminal/mortalidade , Doença Hepática Terminal/cirurgia , Exercício Físico , Fragilidade/reabilitação , Humanos , Cirrose Hepática/cirurgia , Transplante de Fígado , Estado Nutricional , Valor Preditivo dos Testes , Ensaios Clínicos Controlados Aleatórios como Assunto , Sarcopenia/reabilitação , Índice de Gravidade de DoençaRESUMO
OBJECTIVE: To ascertain whether current practice in teaching hospitals in New South Wales and the Australian Capital Territory delivers adequate dietary protein in the management of malnutrition in adults with cirrhosis, in accordance with European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines for nutrition in liver disease. STUDY DESIGN: Cross-sectional study of dietitians using a self-administered, mail-back survey. SETTING: Teaching hospitals in NSW and the ACT treating patients with cirrhosis. PARTICIPANTS: Dietitians seeing patients with cirrhosis in the 12 months prior to completing the survey. MAIN OUTCOME MEASURES: Current dietary protein prescription practice for patients with cirrhosis (with and without hepatic encephalopathy); use of nutritional supplements and enteral feeding for malnourished patients with cirrhosis. RESULTS: Dietitians following the ESPEN guidelines were in the minority: 36% of the dietitians recommended an adequate protein intake for patients with hepatic encephalopathy. Sixty-four per cent of the dietitians had received referrals from the medical team requesting inappropriate protein-restricted diets for patients without hepatic encephalopathy. Seventy-eight per cent of the dietitians requested clarification of the recommended nutritional management of patients with cirrhosis. CONCLUSION: Many medical and dietetic staff inappropriately restrict protein intake of patients with cirrhosis.